Route selection & development

RML Pharma Consulting has expertise in synthetic chemistry and is experienced in developing scaleable and sustainable synthetic routes and processes for GMP manufacture of API.

  • Evaluate your current synthetic route in terms of long term viability.

      • Provide a projected cost of goods for the API to identify potential issues which may preclude the development of your asset for the targeted therapeutic area.

          • Initiate and coordinate a program of process development activity at contract to support the next manufacturing campaign.

              • We can propose and exemplify alternative synthetic routes to your API, addressing specific issues that you may have identified with the current route (eg cost, availability of starting materials).
                • In order to reduce cash burn, we can also carry out a minimal development approach which targets only the development activities needed to get you to your next milestone.